PHAR•benzinga•
Oppenheimer Maintains Outperform on Pharming, Raises Price Target to $39
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 14, 2025 by benzinga